156 related articles for article (PubMed ID: 38010374)
1. Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives.
Li Y; Meng L; Lou G
Cancer Biol Ther; 2023 Dec; 24(1):2285817. PubMed ID: 38010374
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.
Sano R; Kanomata N; Suzuki S; Shimoya K; Sato Y; Moriya T; Shiota M
Tohoku J Exp Med; 2017 Oct; 243(2):107-114. PubMed ID: 29057763
[TBL] [Abstract][Full Text] [Related]
3. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
4. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer.
Feng ML; Sun MJ; Xu BY; Liu MY; Zhang HJ; Wu C
World J Gastroenterol; 2023 Jun; 29(24):3770-3792. PubMed ID: 37426316
[TBL] [Abstract][Full Text] [Related]
6. m
Li Y; Lou S; Zhang J; Zhao S; Lou G
J Transl Med; 2024 Jan; 22(1):113. PubMed ID: 38281945
[TBL] [Abstract][Full Text] [Related]
7. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
9. Significance of vasohibin 1 in cancer patients: A systematic review and meta analysis.
Liu S; Han B; Sun M; Wang J; Sun Y; Wang Y
J Cancer Res Ther; 2022 Apr; 18(2):567-575. PubMed ID: 35645129
[TBL] [Abstract][Full Text] [Related]
10. Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.
Mikami S; Oya M; Kosaka T; Mizuno R; Miyazaki Y; Sato Y; Okada Y
Lab Invest; 2017 Jul; 97(7):854-862. PubMed ID: 28287633
[TBL] [Abstract][Full Text] [Related]
11. Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer.
Qiao S; Hou Y; Rong Q; Han B; Liu P
Transl Oncol; 2023 Jun; 32():101665. PubMed ID: 37018867
[TBL] [Abstract][Full Text] [Related]
12. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.
Zhao G; Yang Y; Tang Y; Han R; Sun Y
Med Oncol; 2012 Dec; 29(5):3325-34. PubMed ID: 22865127
[TBL] [Abstract][Full Text] [Related]
14. Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification.
Aili Y; Maimaitiming N; Maimaiti A; Liu W; Qin H; Ji W; Mahemuti Y; Wang Y; Wang Z
J Oncol; 2022; 2022():2621969. PubMed ID: 36504559
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
[TBL] [Abstract][Full Text] [Related]
16. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration.
Ma D; Li J; Wang J; Sun Z; Wang K
Mol Med Rep; 2017 Aug; 16(2):1479-1485. PubMed ID: 29067450
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Wang H; Deng Q; Lv Z; Ling Y; Hou X; Chen Z; Dinglin X; Ma S; Li D; Wu Y; Peng Y; Huang H; Chen L
Mol Cancer; 2019 Dec; 18(1):181. PubMed ID: 31823788
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion.
Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y
J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
